Hannan Fleiman
Director/Board Member at ABACUS HEALTH PRODUCTS, INC.
Network origin in Hannan Fleiman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
McMaster University
68
| College/University | Other Consumer Services | 68 |
University of Guelph
27
| College/University | Other Consumer Services | 27 |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
20
| Public Company | Biotechnology | 20 |
Field Trip Health, Inc.
 Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada.
8
| Subsidiary | Medical/Nursing Services | 8 |
| Holding Company | Pharmaceuticals: Other | 6 | |
Field Trip Psychedelics, Inc.
 Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada.
6
| Private Company | Medical/Nursing Services | 6 |
CanvasRx, Inc.
 CanvasRx, Inc. Miscellaneous Commercial ServicesCommercial Services CanvasRx, Inc. provides medical cannabis patient outreach service. The company was founded by Joseph Del Moral, Hannan Fleiman and Leo Liao in 2014 and is headquartered in Toronto, Canada.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hannan Fleiman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
BMO Capital Markets Corp. (Canada)
 BMO Capital Markets Corp. (Canada) Investment Banks/BrokersFinance BMO Capital Markets Corp. (Canada) (BMO Capital Markets-Canada) is the Canadian brokerage arm of BMO Capital Markets Corp., a full-service financial services provider in the US. The firm was founded in 1817 and is a subsidiary of BMO Asset Management, Inc., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. Headquartered in Toronto, BMO Capital Markets-Canada provides full-service, institutional brokerage services to corporate, institutional and government clients around the world. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Fixed Income | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| Bayer Pharmaceuticals Corp. | President | ||
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AURORA CANNABIS INC. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Rotman School of Management | College/University | Graduate Degree Masters Business Admin | |
HealthPrize Technologies LLC
 HealthPrize Technologies LLC Packaged SoftwareTechnology Services HealthPrize Technologies LLC provides medication adherence solutions for patients. It offers digital platform that improves medication adherence via combination of education and rewards. The company was founded by Thomas Kottler, Katrina Firlik and James Jorasch in September 2009 and is headquartered in Norwalk, CT. | Packaged Software | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Director of Finance/CFO | |
| RENCO HOLDINGS GROUP LIMITED | Electronic Components | Director/Board Member Director/Board Member | |
CIBC World Markets, Inc.
 CIBC World Markets, Inc. Investment Banks/BrokersFinance CIBC World Markets, Inc. is a full-service Canadian brokerage and investment banking firm headquartered in Toronto, Ontario. The firm was founded in 1961 and is a subsidiary of the Canadian Imperial Bank of Commerce (TSE, NYSE: CM). CIBC World Markets provides alternative investment managers with premier prime brokerage that brings together trade execution, reporting, research and capital introduction with a view to enhancing efficiencies and profitability. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Analyst-Equity Corporate Officer/Principal | |
Scotia Capital, Inc. (Broker)
 Scotia Capital, Inc. (Broker) Investment Banks/BrokersFinance Scotia Capital, Inc. (Broker) (Scotia Capital-Broker) is the broker-dealer division of Scotia Capital, Inc., a full-service financial services firm headquartered in Toronto, Canada. The firm is owned by The Bank of Nova Scotia (NYSE, TSE: BNS). Scotia Capital-Broker delivers a broad range of electronic trading products such as high-touch, low-latency, market access and a broad algorithmic trading suite for a wide range of clients globally. They publish monthly indexes to help investors track the performance of Canadian Hedge Funds and Alternative Mutual Funds. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
National Bank Financial, Inc. (Broker)
 National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
RBC Dominion Securities, Inc.
 RBC Dominion Securities, Inc. Investment ManagersFinance RBC Dominion Securities, Inc. (RBCDS) is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm was founded in 1901 and is a subsidiary of Royal Bank of Canada (TSE, NYSE: RY). RBCDS provides a full spectrum of brokerage services to retail and corporate clients. | Investment Managers | Market Strategist Economist Analyst-Equity | |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Sales & Marketing | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| York University | College/University | Undergraduate Degree Undergraduate Degree | |
| Queen's University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Concordia College (New York) | College/University | Undergraduate Degree | |
| Syracuse University | College/University | Undergraduate Degree Masters Business Admin | |
| Long Island University | College/University | Graduate Degree | |
| University of Ottawa | College/University | Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree Doctorate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Shanghai Jiao Tong University | College/University | Masters Business Admin Masters Business Admin | |
Shanghai University of Finance & Economics
 Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Undergraduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Macquarie Capital Markets Canada Ltd.
 Macquarie Capital Markets Canada Ltd. Investment Banks/BrokersFinance Founded in 2007, Macquarie Capital Markets Canada Ltd. is a broker located in Toronto with additional offices located in Montreal, Vancouver and Calgary. They are a subsidiary of Macquarie Capital Markets North America Ltd. and their ultimate parent is Macquarie Group Ltd. (OTC: MQBKF.PK). Macquarie Capital Markets Canada follows the following sectors: mining, energy, utilities, infrastructure, consumer, technology, financials and real estate. The firm focuses primarily on Canadian-based stocks. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| XINJIANG LA CHAPELLE FASHION CO., LTD. | Apparel/Footwear Retail | Director/Board Member | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
Canadian Cannabis Clinic
 Canadian Cannabis Clinic Hospital/Nursing ManagementHealth Services Canadian Cannabis Clinic is a medical cannabis clinic that helps patients find relief through the use of medical cannabis. The private company is based in Burlington, Canada. The Canadian company is committed to participating in cannabis research and educating the medical industry. The company was founded by Ronan Levy, Hannan Fleiman. | Hospital/Nursing Management | Chief Executive Officer Founder | |
| FIELD TRIP HEALTH & WELLNESS LTD. | Medical/Nursing Services | General Counsel Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| COYA THERAPEUTICS, INC. | Biotechnology | Director/Board Member President | |
Trait Biosciences, Inc.
 Trait Biosciences, Inc. Agricultural Commodities/MillingProcess Industries Trait Biosciences, Inc. engages in the production and cultivation of medicinal cannabis. It develops novel, natural plant technologies that seek to protect crops from mildew, fungus, viruses, and pests as well as developing agricultural technologies leveraging the plant?s natural metabolic pathways to substantially increase yields. The company is headquartered in Vancouver, Canada. | Agricultural Commodities/Milling | Chief Executive Officer Director/Board Member | |
| DeGroote School of Business | College/University | Masters Business Admin Masters Business Admin | |
Juno Pharmaceuticals Corp.
 Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
Algae-C, Inc.
 Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Biotechnology | Director/Board Member |
Statistics
International
| Canada | 25 |
| United States | 17 |
| China | 4 |
| Germany | 3 |
| Japan | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 15 |
| Finance | 10 |
| Health Services | 5 |
| Process Industries | 3 |
Operational
| Director/Board Member | 203 |
| Corporate Officer/Principal | 131 |
| Undergraduate Degree | 94 |
| Founder | 47 |
| Analyst-Equity | 46 |
Most connected contacts
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Dieter Weinand | 32 |
| Jesse Kaplan | 26 |
| Ted Ingemar Jakob Fjällman | 23 |
| Helen Boudreau | 22 |
| Barry Fishman | 22 |
| Gregory Mayes | 18 |
| Ronan Levy | 16 |
| Jun Feng Wang | 16 |
| Lisa Crossley | 15 |
| Joseph del Moral | 15 |
| Michael Verbora | 14 |
| Syed Mujeeb Jafferi | 13 |
| Henry Hague | 12 |
| Nitin Chopra | 11 |
- Stock Market
- Insiders
- Hannan Fleiman
- Company connections
